These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
94 related articles for article (PubMed ID: 4252824)
41. [Metabolic complications of obesity--attempt to influence them by dehydroepiandrosterone sulfate]. Simonová J; Gregorová I; Sonka J Sb Lek; 1973 Jan; 75(1):27-32. PubMed ID: 4265077 [No Abstract] [Full Text] [Related]
42. [Experimental studies of the mechanism of action of chrysarobin and dithranol in psoriasis (evidence for a cytostatic effect on the epidermis)]. Krebs A; Schaltegger H Dermatologica; 1965; 131(1):1-27. PubMed ID: 4284321 [No Abstract] [Full Text] [Related]
43. [Contribution on the knowledge of serum enzymes in psoriasis]. Kipping D Z Haut Geschlechtskr; 1967 Oct; 42(19):759-64. PubMed ID: 5597698 [No Abstract] [Full Text] [Related]
44. Certain erythrocyte constituents in subjects having subnormal glucose-6-phosphate dehydrogenase activity. Amma MK; Ahluwalia P; Sareen K J Assoc Physicians India; 1980; 28(1-2):21-7. PubMed ID: 7216963 [No Abstract] [Full Text] [Related]
46. [Influence of dehydroepiandrosterone on the activity of glucose-6-phosphate-dehydrogenase and on the growth of the Ehrlich ascitic tumor (author's transl)]. Avenariová I; Schwartz E Bratisl Lek Listy; 1975 Dec; 64(6):698-703. PubMed ID: 127649 [No Abstract] [Full Text] [Related]
47. The effects of calcipotriol and methylprednisolone aseponate on bcl-2, p53 and ki-67 expression in psoriasis. Adişen E; Gülekon A; Erdem O; Dursun A; Gürer MA J Eur Acad Dermatol Venereol; 2006 May; 20(5):527-33. PubMed ID: 16684279 [TBL] [Abstract][Full Text] [Related]
54. CTACK /CCL27 expression in psoriatic skin and its modification after administration of etanercept. Campanati A; Goteri G; Simonetti O; Ganzetti G; Giuliodori K; Stramazzotti D; Morichetti D; Bernardini ML; Mannello B; Fabris G; Offidani A Br J Dermatol; 2007 Dec; 157(6):1155-60. PubMed ID: 17916208 [TBL] [Abstract][Full Text] [Related]
55. [Inhibition of glucose-6-phosphate dehydrogenase in human brain tissue. VI. Effect of androstenolone and its conjugates on the activity of glucose-6-phosphate dehydrogenase]. Menzel E; Menzel P; Oertel GW Hoppe Seylers Z Physiol Chem; 1970 Jun; 351(6):759-60. PubMed ID: 4393250 [No Abstract] [Full Text] [Related]
56. A possible interrelation between glucose-6-phosphate dehydrogenase and dehydroepiandrosterone in obesity. Lopez A; Krehl WA Lancet; 1967 Sep; 2(7514):485-7. PubMed ID: 4166407 [No Abstract] [Full Text] [Related]
57. Metabolic changes at the margin of the spreading psoriatic lesion. van de Kerkhof PC; van Rennes H; de Grood R; Bauer FW; Mier PD Br J Dermatol; 1983 Jun; 108(6):647-52. PubMed ID: 6860560 [TBL] [Abstract][Full Text] [Related]
58. [Effect of cold, thyroidine, methylthiouracil and dehydroepiandrosterone on the activity of glucose-6-phosphate dehydrogenase and 6-phosphogluconate dehydrogenase in erythrocytes and liver of rats]. Hilgertová J; Sonka J Sb Lek; 1972 Jul; 74(7):211-7. PubMed ID: 4262111 [No Abstract] [Full Text] [Related]
59. Erythrocyte glucose-6-phosphate dehydrogenase activity in thalassemia and in hemoglobin E. Panich V; Wasi P; Na-Nakorn S J Med Assoc Thai; 1971 Sep; 54(9):630-4. PubMed ID: 5126662 [No Abstract] [Full Text] [Related]
60. Studies on erythrocyte glucose-6-phosphate dehydrogenase activity. Khalil M; Ibrahim AH; el-Khateeb S; Aref K J Trop Med Hyg; 1966 Nov; 69(11):264-7. PubMed ID: 5923909 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]